Mana.bio

Tel Aviv, Israel · Founded 2021 · Privately Held (backing)

Operator of an artificial intelligence-based drug delivery company intended to facilitate lipid nanoparticle development for oligonucleotide therapies. Mana.bio is based in Tel Aviv, Israel and was founded in 2021. Its last reported valuation was $30.8 million in Oct 2023. It has raised $19.5 million.

Last reported valuation

$30.8M

Oct 2026

Priced at

—

Total raised

$19.5M

Last round

—

How much has Mana.bio raised?

$19.5Macross 0 recorded rounds

Free account

More of Mana.bio with a free account

·Watch Mana.bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Mana.bio investors

7 investors are on record for Mana.bio, including Andreessen Horowitz, Gaingels, NFX and Base4 Capital.

For fundraisers

Raising for a company like Mana.bio?

7 investors have backed Mana.bio.

See all 7 investors →

Frequently asked about Mana.bio

How much has Mana.bio raised?: Mana.bio has raised $19.5M in total across 0 recorded funding rounds.